Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).

Perez IM, Jambor I, Kauko T, Verho J, Ettala O, Falagario U, Merisaari H, Kiviniemi A, Taimen P, Syvänen KT, Knaapila J, Seppänen M, Rannikko A, Riikonen J, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Boström PJ, Aronen HJ.

J Magn Reson Imaging. 2019 Nov 21. doi: 10.1002/jmri.26975. [Epub ahead of print]

PMID:
31750988
2.

Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study.

Knaapila J, Jambor I, Perez IM, Ettala O, Taimen P, Verho J, Kiviniemi A, Pahikkala T, Merisaari H, Lamminen T, Saunavaara J, Aronen HJ, Syvänen KT, Boström PJ.

Eur Urol Oncol. 2019 Sep 6. pii: S2588-9311(19)30134-8. doi: 10.1016/j.euo.2019.08.008. [Epub ahead of print]

PMID:
31501082
3.

Ropinirole eye drops induce vomiting effectively in dogs: a randomised, double-blind, placebo-controlled clinical study.

Suokko M, Saloranta L, Lamminen T, Laine T, Elliott J.

Vet Rec. 2019 Aug 13. pii: vetrec-2018-104953. doi: 10.1136/vr.104953. [Epub ahead of print]

PMID:
31409749
4.

Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells.

Kettunen K, Boström PJ, Lamminen T, Heinosalo T, West G, Saarinen I, Kaipio K, Rantala J, Albanese C, Poutanen M, Taimen P.

Eur Urol. 2019 Oct;76(4):430-434. doi: 10.1016/j.eururo.2019.06.016. Epub 2019 Jun 28.

5.

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.

Jambor I, Verho J, Ettala O, Knaapila J, Taimen P, Syvänen KT, Kiviniemi A, Kähkönen E, Perez IM, Seppänen M, Rannikko A, Oksanen O, Riikonen J, Vimpeli SM, Kauko T, Merisaari H, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Aronen HJ, Boström PJ.

PLoS Med. 2019 Jun 3;16(6):e1002813. doi: 10.1371/journal.pmed.1002813. eCollection 2019 Jun.

6.

Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.

Knaapila J, Kallio H, Hakanen AJ, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Gunell M, Boström PJ.

BJU Int. 2018 Aug;122(2):203-210. doi: 10.1111/bju.14198. Epub 2018 Apr 6.

7.

Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.

Knaapila J, Gunell M, Syvänen K, Ettala O, Kähkönen E, Lamminen T, Seppänen M, Jambor I, Rannikko A, Riikonen J, Munukka E, Eerola E, Hakanen AJ, Boström PJ.

Eur Urol Focus. 2019 May;5(3):443-448. doi: 10.1016/j.euf.2017.12.001. Epub 2017 Dec 20.

PMID:
29275146
8.

FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth.

Peippo M, Gardberg M, Lamminen T, Kaipio K, Carpén O, Heuser VD.

Exp Cell Res. 2017 Jan 1;350(1):267-278. doi: 10.1016/j.yexcr.2016.12.004. Epub 2016 Dec 2.

9.

Hydroxysteroid (17beta) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos.

Jokela H, Rantakari P, Lamminen T, Strauss L, Ola R, Mutka AL, Gylling H, Miettinen T, Pakarinen P, Sainio K, Poutanen M.

Endocrinology. 2010 Apr;151(4):1884-92. doi: 10.1210/en.2009-0928. Epub 2010 Feb 25.

PMID:
20185768
10.

Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.

Saloniemi T, Järvensivu P, Koskimies P, Jokela H, Lamminen T, Ghaem-Maghami S, Dina R, Damdimopoulou P, Mäkelä S, Perheentupa A, Kujari H, Brosens J, Poutanen M.

Am J Pathol. 2010 Mar;176(3):1443-51. doi: 10.2353/ajpath.2010.090325. Epub 2010 Jan 21.

11.

Human HSD17B1 expression masculinizes transgenic female mice.

Saloniemi T, Welsh M, Lamminen T, Saunders P, Mäkelä S, Streng T, Poutanen M.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):163-8. doi: 10.1016/j.mce.2008.10.047. Epub 2008 Nov 17.

PMID:
19061935
12.

In vivo mouse model for analysis of hydroxysteroid (17beta) dehydrogenase 1 inhibitors.

Lamminen T, Saloniemi T, Huhtinen K, Koskimies P, Messinger J, Husen B, Thole H, Poutanen M.

Mol Cell Endocrinol. 2009 Mar 25;301(1-2):158-62. doi: 10.1016/j.mce.2008.10.034. Epub 2008 Nov 5.

PMID:
19026716
13.

Activation of androgens by hydroxysteroid (17beta) dehydrogenase 1 in vivo as a cause of prenatal masculinization and ovarian benign serous cystadenomas.

Saloniemi T, Lamminen T, Huhtinen K, Welsh M, Saunders P, Kujari H, Poutanen M.

Mol Endocrinol. 2007 Nov;21(11):2627-36. Epub 2007 Jul 31.

PMID:
17666583
14.

Transgenic male mice expressing human hydroxysteroid dehydrogenase 2 indicate a role for the enzyme independent of its action on sex steroids.

Zhongyi S, Rantakari P, Lamminen T, Toppari J, Poutanen M.

Endocrinology. 2007 Aug;148(8):3827-36. Epub 2007 May 17.

PMID:
17510238
15.

Birth of correctly genotyped calves after multiplex marker detection from bovine embryo microblade biopsies.

Peippo J, Viitala S, Virta J, Räty M, Tammiranta N, Lamminen T, Aro J, Myllymäki H, Vilkki J.

Mol Reprod Dev. 2007 Nov;74(11):1373-8.

PMID:
17440940
16.

Human FSH beta subunit gene is highly conserved.

Lamminen T, Jokinen P, Jiang M, Pakarinen P, Simonsen H, Huhtaniemi I.

Mol Hum Reprod. 2005 Aug;11(8):601-5. Epub 2005 Aug 12.

PMID:
16100240
17.

Luteinizing hormone receptor knockout (LuRKO) mice and transgenic human chorionic gonadotropin (hCG)-overexpressing mice (hCG alphabeta+) have bone phenotypes.

Yarram SJ, Perry MJ, Christopher TJ, Westby K, Brown NL, Lamminen T, Rulli SB, Zhang FP, Huhtaniemi I, Sandy JR, Mansell JP.

Endocrinology. 2003 Aug;144(8):3555-64.

PMID:
12865338
18.

Functional study of a recombinant form of human LHbeta-subunit variant carrying the Gly(102)Ser mutation found in Asian populations.

Lamminen T, Jiang M, Manna PR, Pakarinen P, Simonsen H, Herrera RJ, Huhtaniemi I.

Mol Hum Reprod. 2002 Oct;8(10):887-92.

PMID:
12356936
20.

A common genetic variant of luteinizing hormone; relation to normal and aberrant pituitary-gonadal function.

Lamminen T, Huhtaniemi I.

Eur J Pharmacol. 2001 Feb 23;414(1):1-7. Review.

PMID:
11230989
21.

mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy.

Lamminen T, Huoponen K, Sistonen P, Juvonen V, Lahermo P, Aula P, Nikoskelainen E, Savontaus ML.

Eur J Hum Genet. 1997 Sep-Oct;5(5):271-9.

PMID:
9412783
22.

Mutations in subunit 6 of the F1F0-ATP synthase cause two entirely different diseases.

Majander A, Lamminen T, Juvonen V, Aula P, Nikoskelainen E, Savontaus ML, Wikström M.

FEBS Lett. 1997 Jul 28;412(2):351-4.

23.

Tissue distribution of the ND4/11778 mutation in heteroplasmic lineages with Leber hereditary optic neuropathy.

Juvonen V, Nikoskelainen E, Lamminen T, Penttinen M, Aula P, Savontaus ML.

Hum Mutat. 1997;9(5):412-7.

PMID:
9143920
24.

Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations.

Nikoskelainen EK, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus ML.

Ophthalmology. 1996 Mar;103(3):504-14. Erratum in: Ophthalmology 1996 Jul;103(7):998.

PMID:
8600429
25.

Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy.

Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P, Savontaus ML.

J Neurol Neurosurg Psychiatry. 1995 Aug;59(2):160-4.

26.

A mitochondrial mutation at nt 9101 in the ATP synthase 6 gene associated with deficient oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy.

Lamminen T, Majander A, Juvonen V, Wikström M, Aula P, Nikoskelainen E, Savontous ML.

Am J Hum Genet. 1995 May;56(5):1238-40. No abstract available.

27.

The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy.

Huoponen K, Lamminen T, Juvonen V, Aula P, Nikoskelainen E, Savontaus ML.

Hum Genet. 1993 Oct;92(4):379-84.

PMID:
7901141

Supplemental Content

Loading ...
Support Center